Related Experiment Video
Updated: Jun 5, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
A generalized logrank-type test for comparison of treatment regimes in sequential multiple assignment randomized
Anastasios A Tsiatis1, Marie Davidian1
1Department of Statistics, North Carolina State University, Raleigh, NC 27695-8203, United States.
Abstract:
The sequential multiple assignment randomized trial (SMART) is the ideal study design for the evaluation of multistage treatment regimes, which comprise sequential decision rules that recommend treatments for a patient at each of a series of decision points based on their evolving characteristics. A common goal is to compare the set of so-called embedded regimes represented in the design on the basis of a primary outcome of interest. In the study of chronic diseases and disorders, this outcome is often a time to an event, and a goal is to compare the distributions of the time-to-event outcome associated with each regime in the set. We present a general statistical framework in which we develop a logrank-type test for comparison of the survival distributions associated with regimes within a specified set based on the data from a SMART with an arbitrary number of stages that allows incorporation of covariate information to enhance efficiency and can also be used with data from an observational study. The framework provides clarification of the assumptions required to yield a principled test procedure, and the proposed test subsumes or offers an improved alternative to existing methods. We demonstrate performance of the methods in a suite of simulation studies. The methods are applied to a SMART in patients with acute promyelocytic leukemia.
Related Concept Videos
The Mantel-Cox Log-Rank Test
Comparing the Survival Analysis of Two or More Groups
Friedman Two-way Analysis of Variance by Ranks
Randomized Experiments
Simple randomization
Simple...
Wilcoxon Signed-Ranks Test for Matched Pairs
Hazard Ratio
For example, in a clinical trial...

